These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist. Domenici MR; Sagratella S; Ongini E; Longo R; Scotti de Carolis A Eur J Pharmacol; 1994 Dec; 271(2-3):259-63. PubMed ID: 7705426 [TBL] [Abstract][Full Text] [Related]
43. Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia. Wasterlain CG; Adams LM; Wichmann JK; Sofia RD Stroke; 1996 Jul; 27(7):1236-40. PubMed ID: 8685935 [TBL] [Abstract][Full Text] [Related]
44. Extracellular proton-modulated pore-blocking effect of the anticonvulsant felbamate on NMDA channels. Chang HR; Kuo CC Biophys J; 2007 Sep; 93(6):1981-92. PubMed ID: 17513365 [TBL] [Abstract][Full Text] [Related]
46. [Preliminary assessment of felbamate effect on the cerebral bioelectrical activity in children with refractory epilepsy]. Pakszys M; Rusek G; Kuszczak B; Szamotulska K; Mazur J Neurol Neurochir Pol; 2000; 34 Suppl 1():203-14. PubMed ID: 10768160 [TBL] [Abstract][Full Text] [Related]
47. Glycine-induced CA1 excitotoxicity in the rat hippocampal slice. Wallis RA; Panizzon KL; Nolan JP Brain Res; 1994 Nov; 664(1-2):115-25. PubMed ID: 7895020 [TBL] [Abstract][Full Text] [Related]
48. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist. Kosten TA; DeCaprio JL; Rosen MI Neuropsychopharmacology; 1995 Dec; 13(4):323-33. PubMed ID: 8747757 [TBL] [Abstract][Full Text] [Related]
49. Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels. Kuo CC; Lin BJ; Chang HR; Hsieh CP Mol Pharmacol; 2004 Feb; 65(2):370-80. PubMed ID: 14742679 [TBL] [Abstract][Full Text] [Related]
51. Effect of felbamate on plasma levels of carbamazepine and its metabolites. Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822 [TBL] [Abstract][Full Text] [Related]
52. Felbamate: a new antiepileptic drug. Brodie MJ Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147 [No Abstract] [Full Text] [Related]
53. Effect of felbamate on carbamazepine and its major metabolites. Wagner ML; Remmel RP; Graves NM; Leppik IE Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065 [TBL] [Abstract][Full Text] [Related]
54. [Advantages and disadvantages of new antiepileptic drugs]. Herranz JL Rev Neurol; 1996 Nov; 24(135):1426-34. PubMed ID: 8974750 [TBL] [Abstract][Full Text] [Related]
55. Overview of the safety of newer antiepileptic drugs. Shorvon S; Stefan H Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960 [TBL] [Abstract][Full Text] [Related]
56. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Chronopoulos A; Stafstrom C; Thurber S; Hyde P; Mikati M; Holmes GL Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945 [TBL] [Abstract][Full Text] [Related]
57. A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices. Calabresi P; Siniscalchi A; Pisani A; Stefani A; Mercuri NB; Bernardi G Neurology; 1996 Aug; 47(2):557-62. PubMed ID: 8757038 [TBL] [Abstract][Full Text] [Related]
59. Felbamate. Sofia RD; Kramer L; Perhach JL; Rosenberg A Epilepsy Res Suppl; 1991; 3():103-8. PubMed ID: 1777064 [No Abstract] [Full Text] [Related]
60. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]